Congenital cataract does not greatly affect quality of life in young adults

Article

History of congenital cataract does not affect quality of life or educational achievements in adolescents and young adults.

History of congenital cataract does not affect quality of life or educational achievements in adolescents and young adults, claims a study in the Journal of Paediatric Ophthalmology and Strabismus.

Dr Caitriona Kirwan et al., Mater Private Hospital, Dublin, Ireland, performed a retrospective chart review on patients who underwent cataract surgery below the age of 24 months. The National Eye Institute 25-item Visual Function Questionnaire (NEI-VFQ-25) was used to assess vision-specific health-related quality of life in adolescents and young adults. A control group of healthy volunteers with no visual complaints was also included in the study.

Unilateral cataract was recorded in 16 patients, bilateral cataract in 22 patients and 15 people were in the control group. The bilateral participants experienced greater difficulty with regards to near and distance activities, compared to the unilateral group.

Between the unilateral and control group there were no significant differences in ocular pain, vision-specific social functioning, role difficulties and dependency scores. All patients attended main-stream school and the majority had attended university, meaning educational achievements were high in both cataract groups.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.